Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) Invested Capital: 2011-2025

Historic Invested Capital for Mesa Laboratories (MLAB) over the last 15 years, with Sep 2025 value amounting to $183.2 million.

  • Mesa Laboratories' Invested Capital fell 29.14% to $183.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $183.2 million, marking a year-over-year decrease of 29.14%. This contributed to the annual value of $257.1 million for FY2025, which is 76.85% up from last year.
  • According to the latest figures from Q3 2025, Mesa Laboratories' Invested Capital is $183.2 million, which was down 32.15% from $269.9 million recorded in Q2 2025.
  • Mesa Laboratories' Invested Capital's 5-year high stood at $406.5 million during Q1 2021, with a 5-year trough of $145.4 million in Q1 2024.
  • In the last 3 years, Mesa Laboratories' Invested Capital had a median value of $258.5 million in 2024 and averaged $281.6 million.
  • In the last 5 years, Mesa Laboratories' Invested Capital soared by 84.32% in 2021 and then crashed by 63.05% in 2024.
  • Mesa Laboratories' Invested Capital (Quarterly) stood at $396.3 million in 2021, then declined by 2.30% to $387.2 million in 2022, then climbed by 4.07% to $403.0 million in 2023, then slumped by 36.19% to $257.1 million in 2024, then decreased by 29.14% to $183.2 million in 2025.
  • Its Invested Capital was $183.2 million in Q3 2025, compared to $269.9 million in Q2 2025 and $257.1 million in Q1 2025.